V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10354078 | 10040025 | 0 | 0 | null | 2017-07-30 | 2017-08-06 | Venetoclax | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101418981 |
| 10354127 | 10040026 | 1.65 | 0 | Not known (9) | 2018-11-12 | 2018-11-12 | POMALIDOMIDE | 02 | null | IPILIMUMAB + NIVOLUMAB | 100654090 |
| 10354140 | 10040027 | 1.78 | 80 | Palliative (P) | 2017-09-11 | 2017-09-11 | Temozolomide 200mg/m2 | N | N | TEMOZOLOMIDE | 100865149 |
| 10354576 | 10040029 | 1.48 | 0 | Neo-adjuvant (N) | 2017-07-31 | 2017-07-31 | MITOMYCIN | 02 | N | CAPECITABINE + GEMCITABINE | 101148300 |
| 10354581 | 10040030 | 0 | 60.3 | 03 | 2018-03-13 | 2018-03-17 | Acalabrutinib | 02 | N | ACALABRUTINIB | 100820369 |
| 10354777 | 10040031 | 1.77 | 95.7 | Palliative (P) | 2017-12-17 | 2017-12-19 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100516461 |
| 10355267 | 10040032 | 1.8 | 62.8 | Curative (C) | 2018-09-28 | 2018-10-14 | Sunitinib | 02 | N | CYTARABINE | 101637425 |
| 10355560 | 10040033 | 1.72 | 91.4 | null | 2021-10-27 | 2021-11-05 | FEC + DOCETAXEL | null | null | POMALIDOMIDE | 101498072 |
| 10355693 | 10040034 | 1.78 | 86.9 | null | 2019-10-15 | 2019-11-05 | Sunitinib | 02 | null | SUNITINIB | 100860209 |
| 10355992 | 10040035 | 1.61 | 70 | null | 2018-07-19 | 2018-09-22 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101302707 |
| 10356147 | 10040036 | 1.69 | 88 | null | 2019-11-21 | 2019-11-23 | Temozolomide 200mg/m2 | N | null | TEMOZOLOMIDE | 101273393 |
| 10356165 | 10040037 | 0 | 57.5 | 02 | 2019-10-25 | 2019-11-01 | CHOP R - 21 days | 02 | N | CHOP R | 100424467 |
| 10356245 | 10040038 | 1.66 | 59 | Curative (C) | null | 2018-01-26 | Cyclophosphamide + Docetaxel | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100642985 |
| 10356446 | 10040039 | 1.76 | 59.8 | Palliative (P) | 2018-06-25 | 2018-06-25 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101175884 |
| 10356697 | 10040040 | 1.68 | 67.1 | Palliative (P) | 2020-07-16 | 2020-07-20 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101738276 |
| 10356713 | 10040041 | 1.82 | 73 | Palliative (P) | null | 2019-04-25 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 101265689 |
| 10357106 | 10040043 | 1.62 | 70.9 | 03 | 2019-01-23 | 2019-01-23 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101026641 |
| 10357265 | 10040044 | 1.75 | 67.2 | 03 | 2018-02-23 | 2018-02-23 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100356773 |
| 10357541 | 10040046 | 1.86 | 70.75 | null | 2018-05-05 | 2018-06-08 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100923745 |
| 10357803 | 10040047 | 1.77 | 79.25 | 03 | 2019-01-10 | 2019-01-13 | FEC 60 or 75 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100743032 |
| 10357855 | 10040048 | 1.57 | 88 | Adjuvant (A) | 2019-10-27 | 2019-10-27 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101394004 |
| 10357955 | 10040049 | 1.64 | 87.8 | 02 | 2020-03-03 | 2020-03-03 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 100153601 |
| 10358014 | 10040051 | 1.73 | 66.7 | null | 2022-05-11 | 2022-05-15 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100244997 |
| 10358064 | 10040052 | 1.52 | 70 | Neo-adjuvant (N) | 2022-04-26 | 2022-04-29 | CLADRIBINE | 02 | N | CYTARABINE | 100174210 |
| 10358543 | 10040053 | 0 | 0 | null | 2019-04-03 | 2019-04-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100778465 |
| 10358736 | 10040054 | 1.75 | 102.9 | null | 2019-12-28 | 2020-01-09 | Sunitinib | 02 | null | IPILIMUMAB + NIVOLUMAB | 100820543 |
| 10358907 | 10040055 | 1.77 | 54 | null | 2019-05-27 | 2019-07-16 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100331139 |
| 10358962 | 10040056 | 1.61 | 78 | Neo-adjuvant (N) | 2020-06-08 | 2020-06-08 | Temozolomide + RT | 02 | N | TEMOZOLOMIDE | 101163047 |
| 10359193 | 10040058 | 1.5 | 65 | Palliative (P) | 2021-12-25 | 2021-12-25 | Avelumab | null | null | AVELUMAB | 100567201 |
| 10359234 | 10040060 | 1.82 | 77 | Palliative (P) | 2019-02-11 | 2019-02-13 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100270520 |
| 10359341 | 10040061 | null | null | Curative (C) | 2019-11-07 | 2019-11-07 | FEC 100 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101705819 |
| 10359365 | 10040063 | 0 | 67.8 | Neo-adjuvant (N) | 2017-03-24 | 2017-03-27 | Temozolomide 200mg/m2 | 02 | N | TEMOZOLOMIDE | 101291666 |
| 10359394 | 10040064 | 1.65 | null | null | 2017-03-13 | 2017-03-13 | Venetoclax | 02 | null | DABRAFENIB + TRAMETINIB | 100636537 |
| 10359617 | 10040066 | 1.51 | 84.6 | Curative (C) | 2017-12-28 | 2018-01-05 | Bortezomib +/- Dexamethasone | N | null | BORTEZOMIB | 101015485 |
| 10360900 | 10040069 | 1.84 | 82 | Palliative (P) | 2017-07-24 | 2017-07-24 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101715760 |
| 10361328 | 10040070 | null | null | null | 2022-03-14 | 2022-03-14 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | DABRAFENIB + TRAMETINIB | 100029162 |
| 10361548 | 10040071 | 1.56 | 78 | 03 | 2020-02-05 | 2020-02-22 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100295419 |
| 10361740 | 10040072 | 1.75 | 39.35 | 03 | 2018-02-22 | 2018-03-01 | Folfirinox | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100838003 |
| 10362018 | 10040073 | 1.72 | 79.6 | null | null | 2019-01-17 | Busulfan Oral | 02 | null | DARATUMUMAB | 101587123 |
| 10362608 | 10040075 | 1.8 | 73.8 | Palliative (P) | 2016-03-14 | 2018-05-18 | CVP R | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100483769 |
| 10362620 | 10040076 | 1.57 | 64 | Palliative (P) | 2018-12-12 | 2018-12-12 | IPILIMUMAB + NIVOLUMAB | N | N | IPILIMUMAB + NIVOLUMAB | 101770265 |
| 10362682 | 10040077 | 1.74 | 73 | Neo-adjuvant (N) | 2020-10-03 | 2020-10-03 | Acalabrutinib | 02 | N | ACALABRUTINIB | 100323336 |
| 10362688 | 10040078 | 1.84 | 87.8 | Curative (C) | 2016-12-30 | 2016-12-30 | Venetoclax | N | N | BUSULFAN | 100170131 |
| 10363135 | 10040079 | 1.61 | 94.4 | Neo-adjuvant (N) | 2018-12-12 | 2018-12-12 | CHOP R - 21 days | 02 | N | CHOP R | 101042868 |
| 10363578 | 10040080 | null | 125 | Adjuvant (A) | 2019-01-25 | 2019-01-31 | Cyclophosphamide + Docetaxel | 02 | null | CAPECITABINE + CISPLATIN | 100493434 |
| 10363855 | 10040081 | 1.67 | 0 | Curative (C) | 2021-09-15 | 2021-09-15 | Trial Unspecified | 02 | N | BUSULFAN | 101583433 |
| 10364242 | 10040083 | 1.79 | 91.3 | null | 2018-11-19 | 2018-11-19 | Busulfan Oral | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 100840365 |
| 10364315 | 10040085 | 1.77 | 78.5 | Neo-adjuvant (N) | 2019-02-01 | 2019-02-01 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101707766 |
| 10364425 | 10040087 | 1.78 | 66.6 | Palliative (P) | 2019-08-29 | 2019-09-13 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | null | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101607319 |
| 10364764 | 10040089 | 1.48 | 121.6 | null | 2018-06-19 | 2018-07-07 | Pazopanib | 02 | null | BCG | 101416604 |